Calling for Potential Candidates: Texas Armed Services Scholarship

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Mission Texas – State Representative Sergio Muñoz, Jr. is seeking to nominate a bright and dedicated individual for the Texas Armed Services Scholarship (TASSP), a $10,000 per year award for up to four years. This individual must be enrolled in a Reserve Officers’ Training Corps (ROTC) at a Texas institution of higher education and must commit to serving our country in a recognized military organization.

“The young men and women who are eligible for or have accepted these scholarships have my complete respect,” said Rep. Muñoz. “These students are dedicated to higher learning and to serving our Nation through the military; I could not be more proud to be associated with this program.”

The Texas Legislature created the TASSP to encourage students to participate in ROTC programs at civilian colleges. A student must meet specific eligibility criteria in order to receive an initial award. In addition to the eligibility criteria, a student must enter into an agreement requiring a four-year commitment as a member of the Texas Army National Guard, Texas Air National Guard, Texas State Guard, U.S. Coast Guard, U.S. Merchant Marine or a commissioned officer in any branch of the armed services of the United States. A maximum of 185 students may be appointed annually. A student may receive up to $10,000 for the 2014-2015 academic year and dependent on funding available, students may receive up to four years of awards.

- Advertisement -

Nominations for the 2014-2015 TASSP are now open for next year’s class (fall 2014/spring 2015 academic year), and Rep. Muñoz is looking for a potential student to nominate. Interested applicants can visit https://www.hhloans.comand click on the TASSP link for further details, and contact Rep. Muñoz’ Chief of Staff, Richard Sanchez, directly at 956-584-8999 or by email atRichard.Sanchez@house.state.tx.us for nomination requests.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.
- Advertisement -